You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 155 No. 4, 27 FEBRUARY 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigations
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Digital Rectal Examination on Serum Prostate-Specific Antigen in a Primary Care Setting

Internal Medicine Clinic Research Consortium; Coleen M. Andruss, MD; Thomas J. Dinella, MD; David S. Macpherson, MD, MPH; Anthony P. Pietropaoli, MD; Lana Tsao, MD; Jill Wachman, MD; Jeff Whittle, MD, MPH; Coleen M. Andruss, MD; Mary L. Cameron, MD; Janet M. Hines, MD; David S. Macpherson, MD, MPH; Melissa McNeil, MD; Lana Tsao, MD; Jeff Whittle, MD, MPH; Joseph Conigliaro, MD, MPH; C. Bernie Good, MD, MPH; Steven E. Labkoff, MD; Colleen M. Andruss, MD; Mary L. Cameron, MD; Mitchell G. Cohen, MD; Anita Deswal, MD; Thomas Dinella, MD; Mark D. Gulinson, MD; Laurie M. Hankin, MD; Michael S. Heinle, MD; Carol J. Higham, MD; Janet M. Hines, MD; Erika L. Hoffman, MD; Richard H. Hunn, MD; Timothy M. Hunter, MD; Laurance W. Kam, MD; Robert J. Leon, MD; Steven Lilie, MD; Joseph L. Lipinski, MD; Lisa A. Marr, MD; Kevin J. McCullum, MD; Glenn C. Michelson, MD; David A. Nace, MD; Daniel J. O'Rourke, MD; Jennifer L. Osborn, MD; William J. Pendergast, MD; Mark A. Provensano, MD; Lisa C. Ramsey, MD; Lawrence C. Reardon, MD; Marc I. Sandberg, MD; John J. Szawaluk, MD; Lana Tsao, MD; Sander van Cleeff, MD; Michele A. Young, MD; Emily L. Yee, MD; Robert K. Zeldin, MD; Karl E. Bushman, MD; Anthony P. Pietropaoli, MD; David S. Richards, MD; Jill, MD; Virginia Balderston, MD; Karen E. Caldwell, MD; Mark E. Collins, MD; Edward G. Dianesi, MD; Caroline G. Dale, MD; Julia M. Dippl, MD; Michael W. Finikiotis, MD; Robert G. Finkel, MD; David M. Friedland, MD; Robert S. Gorby, MD; Ruth Ann Guilinger, MD; Robert J. Hally, MD; Samuel I. Hammerman, MD; James V. Harris, MD; Kathleen J. Keyes, MD; Steven E. Labkoff, MD; Rosemarie A. Leuzzi, MD; Caroline J. Lubick, MD; Michael A. McGuiness, MD; Donna C. Needleman, MD; Robert J. Pritchard, MD; Mariellen T. Rodman, MD; Stephen G. Rohn, MD; Dawn M. Santora, MD; Edward J. Schloss, MD; Thomas A. Selvaggi, MD; Todd D. Shuster, MD; Alan R. Stein, MD; Leighton J. Sweet, MD; Steven T. Tee, MD; Abraham Thomas, MD; Richard C. Hogan, MD; Erol M. Kosar, MD; Thomas I. Murtaugh, MD; Joseph Conigliaro, MD, MPH; C. Bernie Good, MD, MPH; Jennifer Hartle, MPH; Richard P. Lofgren, MD, MPH; David S. Macpherson, MD; MPH; Melissa McNeil, MD; Jeff Whittle, MD, MPH

Arch Intern Med. 1995;155(4):389-392.


Abstract

Background
Measurement of serum prostate-specific antigen (PSA) and digital rectal examination (DRE) are commonly used for prostate cancer screening. Clinicians have been advised to avoid measuring serum PSA after DRE because of the possibility of spurious elevation. However, studies in healthy volunteers have found no change. We sought to determine whether DRE performed by internists affects PSA levels in a primary care clinic population.

Methods
Men older than 49 years enrolled in a Veterans Affairs internal medicine clinic were eligible for the study. For all patients, prostate size and nodularity were assessed by DRE. Blood for determination of PSA levels was drawn immediately before DRE and 30 minutes after DRE. All patients completed a questionnaire regarding voiding.

Results
Two hundred two men aged 50 to 85 years (mean, 67 years) were enrolled and had complete data. The mean PSA level increased by 0.26 µg/L after DRE (P<.001). Six patients (2.9%; 95% confidence interval, 0.6% to 5.3%) had an increase in PSA level from less than 4 µg/L to more than 4 µg/L after DRE. There was a statistically significant but weak correlation between voiding score and PSA level (coefficient.17; P=.02). Patients with an enlarged prostate gland had higher PSA levels than did patients with normal prostates or borderline results of examination. Nodularity did not predict an increased PSA level.

Conclusions
We conclude, in an elderly veteran population, that DRE causes a statistically significant but clinically insignificant increase in serum PSA level. Additionally, we found that symptoms and physical examination results cannot be used to select a population for whom PSA screening would likely be useful.

(Arch Intern Med. 1995;155:389-392)



Author Affiliations

Protocol Development Committee; Data Entry and Analysis Committee; Participating House staff


Footnotes

Participating members of the Internal Medicine Clinic Research Consortium are listed on page 392.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

DRE-PSA Data Revisited: PSA Sampling Should Precede DREs
Douville and Cembrowski
Arch Intern Med 1996;156:1352-1352.
ABSTRACT  

DOES RECTAL EXAM INCREASE PSA LEVELS?
JWatch General 1995;1995:6-6.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.